A former Florida deputy was sentenced to five years of probation for aggravated animal cruelty. Nicholas Zotto was found guilty after a dog in his care suffered sores and severe dehydration. His ...

Next September, Dallas-based Tango Charities plans to gather more than 10,000 people across 100 nationwide events to prepare 250,000 meals in one morning to fight hunger in the United States. The Feed ...

On October 23, 2025, Tango Therapeutics announced positive data from its Phase 1/2 trial of Vopimetostat (TNG462) in MTAP-deleted cancers and completed both a US$209.99 million follow-on equity ...

The new Bar Tango on Capitol Hill brings back the spirit of the original Tango Restaurant & Lounge, which closed in 2019, 13 years after Seattle restaurateur Travis ...

Tango Therapeutics (NASDAQ:TNGX) added ~15% in the premarket on Thursday after the oncology-focused biotech announced an early-stage trial readout for its anticancer agent vopimetostat (TNG462) in ...

Tango Therapeutics (TNGX) shares have drawn attention after a strong run this year, gaining over 170% year-to-date. Investors are now watching closely for clues on whether the momentum can continue as ...

TALLAHASSEE — A federal judge this week rejected a challenge to a 2023 decision by the Escambia County School Board to remove the book “And Tango Makes Three” from school libraries, ruling the move ...

A former Florida county sheriff's deputy was found guilty of aggravated animal cruelty. Nicholas Anthony Zotto was arrested in December 2023 for issues related to his dog-sitting business. One dog ...

A jury found a former Florida deputy guilty of animal cruelty nearly two years after complaints about his Palmetto pet-sitting business drew outrage and an online petition. The case centered on ...

It takes two to tango but apparently just one after-party to ruin a reputation. A suburban Seattle man and tango enthusiast claims a gin-soaked late-night gathering at a California Airbnb with his ...

Tango Therapeutics, Inc. remains a high-risk, high-reward biotech, focused on PRMT5 inhibitors for MTAP-deleted cancers—a large, underserved market opportunity. Disappointing clinical data last ...